Vaccination of children in low-resource countries against Shigella is unlikely to present an undue risk of reactive arthritis

Vaccine

Volumn 27, Issue 40, 2009, Pages 5432-5434

  Gaston, J S Hill ^a   Inman, Robert D ^b   Ryan, Edward T ^c   Venkatesan, Malabi M ^d   Barry, Eileen M ^e   Hale, Thomas L ^f   Bourgeois, A Louis ^f   Walker, Richard I ^f  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF TORONTO   (Canada)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^e University of Maryland School of Medicine Center for Vaccine Development   (United States)

^f PATH   (United States)

Author keywords

Reactive arthritis; Shigellosis; Vaccination

Indexed keywords

HLA B27 ANTIGEN; INACTIVATED VACCINE; LIVE VACCINE; SHIGELLA VACCINE;

CLINICAL TRIAL; DEVELOPING COUNTRY; HUMAN; INFECTION PREVENTION; INFECTION RISK; LETTER; MORBIDITY; MORTALITY; PHENOTYPE; PRIORITY JOURNAL; REACTIVE ARTHRITIS; SHIGELLA; SHIGELLOSIS; VACCINATION;

ARTHRITIS, REACTIVE; CHILD; DEVELOPING COUNTRIES; DYSENTERY, BACILLARY; HLA-B27 ANTIGEN; HUMANS; RISK FACTORS; SHIGELLA; SHIGELLA VACCINES; VACCINATION;

EID: 68349131614     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.06.107     Document Type: Letter

References (11)

1. Kotloff K.L., Winickoff J.P., Ivanoff B., Clemens J.D., Swerdlow D.L., Sansonetti P.J., et al. Global burden of Shigella infections: implication for vaccine development and implementation of control strategies. Bull World Health Org 77 8 (1999) 651-666
2. Hannu T., Mattila L., Siitonen A., and Leirisalo-Repo M. Reactive arthritis attributable to Shigella infection: a clinical and epidemiological nationwide study. Ann Rheum Dis 64 (2005) 594-598
3. Cox C.J., Kempsell K.E., and Gaston J.S.H. Investigation of infectious agents associated with arthritis by reverse transcription PCR of bacterial rRNA. Arthritis Res Ther 5 (2002) R1-R8
4. Probst P., Hermann E., and Fleischer B. Role of bacteria-specific T cells in the immunopathogenesis of reactive arthritis. Trends Microbiol 2 9 (1994) 329-332
5. Stiegliz H., and Lipsky P. Association between reactive arthritis and antecedent infection with Shigella flexneri carrying a 2-Md plasmid and encoding an HLA B27 mimetic epitope. Arithritis Rheum 36 (1993) 1387-1391
6. Gaston H.J.S. Shigella induced reactive arthritis. Ann Rheum Dis 64 (2005) 517-518
7. Khan M.A., Askari A.D., Braun W.E., and Aponte C.J. Low association of HLA-B27 with Reiter's syndrome in blacks. Ann Intern Med 90 2 (1979) 202-203
8. Mathieu A., Cauli A., Fiorillo T., and Sorrentino R. HLA-B27 and ankylosing spondylitis geographic distribution versus malaria endemic: casual or causal liaison?. Ann Rheum Dis 67 1 (2008) 138-140
9. Njobvu P., McGill P., Kerr H., Jellis J., and Pobee J. Spondyloarthrophy and human immunodeficiency virus infection in Zambia. J Rheumatol 25 8 (1998) 1553-1559
10. Schiellerup P., Krogfelt K.A., and Locht H. A comparison of self-reported joint symptoms following infection with different enteric pathogens: effect of HLA-B27. J Rheumatol 35 3 (2008) 480-487
11. Kosek M., Yori P.P., Pan W.K., Olortegui M.P., Gilman R.H., Perez J., et al. Epidemiology of highly endemic, multiply antibiolic-resistant shigellosis in children in the Peruvian Amazon. Pediatrics 122 3 (2008) 541-549